Biopharmaceutical Research Company (BRC), a Monterey, California-based organization which holds a valid Drug Enforcement Administration (DEA) pharmaceutical cannabis license, in Series A funding raised a total of $20 million. Achari Ventures, Argonautic Ventures, AFI Capital Partners, Self Health America, Delta Emerald Ventures, and several distinguished private equities participated in the round, which Intrinsic Capital Partners spearheaded.
The new cannabis beverage boom isn’t really about replacing booze. It’s about replacing everything people…
Amber Senter co-founded Supernova Women, the organization that helped shape America’s first cannabis social equity…
The finding: states that legalized medical or recreational marijuana saw significant reductions in non-fatal opioid…
Eighty-eight percent. Let that sit for a moment. According to the latest nationwide polling from…
A story that once sounded like peak internet fantasy has taken a very real turn. …
Your June 2026 horoscopes brings a powerful mix of growth, reflection, and fresh opportunities. The…